Frequently asked questions about GLP-1 therapy, compounded medications, and the providers we review. For deeper coverage, see our guides and myths vs facts pages.
Is compounded GLP-1 legal?
Yes, when prepared by a licensed 503A pharmacy for individual patients with valid prescriptions, or by a 503B FDA-registered outsourcing facility under specific rules. The legal framework was established by the Drug Quality and Security Act of 2013. The enforcement landscape changes as shortage status and ingredient rules evolve. See our 503A vs 503B guide.
Is compounded semaglutide the same as Ozempic or Wegovy?
Compounded semaglutide is made with the drug in the branded products, but they are different products. Branded products are FDA-approved finished drugs; compounded preparations are not FDA-approved as finished products. Manufacturing standards, excipients, concentration, and container differ. See our myths vs facts.
Which GLP-1 programs print the lowest prices?
There is no single answer for the whole market. Among the compounded programs in our price table (reads of October 15 and November 6, 2026), the lowest standing month-to-month rates were Mondae ($126 tirzepatide, $87 semaglutide) and Eden Health ($129 and $99); NexLife, our editorial pick, charges $129 and $109. Lower figures exist with sales, prepaid terms or memberships. See the lowest printed prices.
Will insurance cover Wegovy or Zepbound?
Variable. Many commercial plans cover Wegovy and Zepbound for weight indication with prior authorization; some plans exclude weight-management drugs as employer-elected. Medicare Part D plans may cover Wegovy for its cardiovascular indication (since March 2024), and the Medicare GLP-1 Bridge offers a $50 copay for eligible enrollees through December 31, 2027. See our insurance coverage guide.
How much weight can I expect to lose?
In trials: 14.9% mean weight loss with semaglutide 2.4 mg vs 2.4% with placebo at 68 weeks (STEP-1); 20.9% with tirzepatide 15 mg vs 3.1% with placebo at 72 weeks (SURMOUNT-1, treatment-regimen estimand). Individual response varies. Results depend on dose, adherence, and lifestyle factors (protein intake, resistance training).
Do I need to take GLP-1 forever?
Generally, yes — obesity is a chronic disease and discontinuation produces weight regain (STEP-4 trial). Some patients maintain weight loss with structured lifestyle change after a period on GLP-1, but the default expectation should be long-term therapy.
What about side effects?
Nausea, constipation, and reduced appetite are common, mostly during titration. Most resolve as dose stabilizes. Severe persistent abdominal pain, severe vomiting, or right-upper-quadrant pain warrant evaluation. See our side effects guide.
Can I drink alcohol on GLP-1?
Yes, but many patients describe markedly reduced desire and tolerance for alcohol. This is a well-documented class effect. No specific contraindication, but slow consumption and watch tolerance.
Will GLP-1 affect my muscle mass?
Rapid weight loss reduces lean mass alongside fat. Resistance training and adequate protein intake (1.6–2.0 g/kg of target body weight) shift the ratio in favor of fat loss. Especially important for patients over 40 — see our men 40+ page.
Can I get pregnant while on GLP-1?
GLP-1 therapy is contraindicated in pregnancy. Stop semaglutide ≥2 months and tirzepatide ≥1 month before any planned conception. GLP-1 may restore ovulation in patients with weight-related anovulation — unexpected pregnancy is well documented. Use reliable contraception if pregnancy is not desired.
What if I miss a weekly dose?
If <48 hours late: take as soon as possible, resume normal schedule. If >48 hours: skip the missed dose, take the next regularly scheduled dose. Don't double up. If multiple doses missed: consult prescriber.
Is NexLife legit?
NexLife's pages name its medical director (Adam Kennah, M.D.) and three state-licensed 503A pharmacies, and publish prices, cancellation and refund terms. That makes its claims checkable, not proven. This site earns commissions from NexLife; see Is NexLife legit? and our conflicts of interest page.